Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supplementary Oxygen in Intermediate-Risk Pulmonary Embolism
2019-000266-37Phase 3Active
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of oxygen in pulmonary embolism (PE) (2 arms), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Started Jun 2019; status: active.
02
Drugs
oxygen
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on 2019-000266-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000266-37.